Share this article
Share this article
WASHINGTON, Jan. 14, 2021 /PRNewswire/ The American College of Emergency Physicians (ACEP) applauds the U.S. Department of Health and Human Services (HHS) decision to effectively remove the X-waiver requirement for physicians, expanding their ability to utilize medication-assisted treatment (MAT) for patients struggling with opioid use disorder (OUD). As emergency physicians, we see every day the devastating effects that the opioid crisis has had on the communities we serve a crisis that has unfortunately only worsened during the COVID-19 pandemic, said Mark Rosenberg, DO, MBA, FACEP, president of ACEP. Buprenorphine is the most important medication in our arsenal for treating opioid use disorder, which is currently one of the most lethal diseases for Americans.
Trump Administration Will Let More Doctors Prescribe Drug To Fight Opioid Addiction
knpr.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from knpr.org Daily Mail and Mail on Sunday newspapers.
KUOW - Trump Administration Will Let More Doctors Prescribe Drug To Fight Opioid Addiction
kuow.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kuow.org Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
FDA Clears Deep Learning Application to Support Image Interpretation with Hyperfine’s Swoop™ .
HyperfineJanuary 14, 2021 GMT
Hyperfine Research, Inc. has received 510(k) clearance from the US FDA for its deep-learning image analysis software. These Advanced AI Applications measure brain structure and pathology in images acquired by the category-defining Swoop™ Portable MR Imaging System through tools featuring automatic measurement of ventricular volume, brain extraction, brain alignment, and midline shift a clinical measure of brain injury.
Hyperfine Research, Inc. has received 510(k) clearance from the US FDA for its deep-learning image analysis software. These Advanced AI Applications measure brain structure and pathology in images acquired by the category-defining Swoop™ Portable MR Imaging System through tools featuring automatic measurement of ventricular volume, brain e